GEMCITABINE(G)-ERLOTINIB(E) VERSUS GEMCITABINE-ERLOTINIB-CAPECITABINE(C) IN THE FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC PANCREATIC CANCER (MPC): EFFICACY AND SAFETY RESULTS OF A PHASE IIB RANDOMIZED STUDY FROM SPANISH TTD COLLABORATIVE GROUP

Authors Benavides, M., Gallego, J., Guillén-Ponce, C., Vera, R., Iranzo, V., Alés, I. -More
Category Primary study
JournalANNALS OF ONCOLOGY
Year 2014
Links DOI
This article has no abstract
Epistemonikos ID: 46c319094309e330c4bc965da8121cb3d382633c
First added on: Feb 07, 2025